Research IT project TraIT is granted €2.25 million from the Dutch Cancer Society to build an integrated Dutch biomedical research infrastructure. By gathering, processing and storing data on a large scale, more and more opportunities in cancer[…]
[ Read more ]
On 10 November The Hyve attended the personal health train workshop in Utrecht, which was organized for the active members of and all parties interested in the Personal Health Train (PHT) initiative.
[ Read more ]
We recently visited Health RI, a conference on research infrastructure, personalized medicine and health care. Organized by BBMRI-NL, ELIXIR-NL, EATRIS-NL, DTL, FHI and FMS, and with The Hyve being one of the sponsors, the conference focused on the[…]
[ Read more ]
Kees van Bochove, CEO of The Hyve, recently had an interview about the highlights of the Utrecht University. The Hyve is one of the highlights. Read here the whole interview about The Hyve.
[ Read more ]
Recently we participated in yet another major scientific conference, ECCB 2016, 15th European Conference on Computational Biology, which is considered the main computational event in 2016. Our sponsorship was very welcome and facilitated the[…]
[ Read more ]
The last couple of months have been busy at The Hyve. Next to all the projects, another big project started, the moving of The Hyve. It has been an excited period for the whole team. Harry van Haaften, CFO, and Jojanneke Blaak, assistant HR &[…]
[ Read more ]
Harvard Business School (HBS) announced on the 20th of May 2016, that Dana-Farber's MatchMiner has been named the winner of the Precision Trials Challenge.
[ Read more ]
Harvard Business School (HBS) announced on the 20th of May 2016, that Dana-Farber's MatchMiner has been named the winner of the Precision Trials Challenge.
[ Read more ]
The Hyve Achieves CIOReview Ranking for 20 Most Promising Biotech Technology Solution Providers 2016
The Hyve, joins an elite number of companies that have earned a spot on 20 Most Promising Biotech Technology Solution Providers list of 2016 by CIOReview. In a deliberate session with the honorary industrial experts, a list of 20 Most Promising[…]
[ Read more ]
An upcoming area of interest for biopharmaceutical product development, as well as for public health and healthcare system evaluation, is the study of medical outcomes in so-called 'real world data'. This data can originate from electronic medical[…]
[ Read more ]